Makes carotid stents for treating carotid artery disease.
Jun 2026Revenue $10.8M/yrExpenses $64.4M/yr
No trendCash runway ≈ 9 months from Jun 2026
Figures by year
When will InspireMD be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $10.8M and expenses $64.4M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $8.98M | $58.6M | −$49.6M |
| Dec 2024 | $7.01M | $40.5M | −$33.5M |
| Dec 2023 | $6.21M | $27.3M | −$21.1M |
| Dec 2022 | $5.17M | $23.9M | −$18.7M |
| Dec 2021 | $4.50M | $19.2M | −$14.7M |
| Dec 2020 | $2.48M | $12.9M | −$10.4M |
| Dec 2019 | $3.72M | $13.5M | −$9.82M |
| Dec 2018 | $3.60M | $11.2M | −$7.61M |
| Dec 2017 | $2.76M | $11.0M | −$8.23M |
| Dec 2016 | $1.89M | $9.54M | −$7.65M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.